- recruitingPHASE1
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
This study is looking at a new medicine, LY4584180, for adults with certain blood cancers like lymphoma that have already been treated. We want to see if it's safe, how well it works, and how the body handles it. The study could last about 9 months or more.
United States · France · Germany - recruitingPHASE1, PHASE2
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
This study tests a new 'off-the-shelf' CAR-T cell therapy, Allo-QuadCAR01-T, for hard-to-treat B-cell cancers like lymphoma. It uses donor cells that target two cancer markers, aiming to be faster and potentially more effective than current treatments. Researchers will check its safety and how well it works.
United States · Germany